BDX
Price
$158.08
Change
+$5.18 (+3.39%)
Updated
Jul 2 closing price
Capitalization
43.56B
25 days until earnings call
Intraday BUY SELL Signals
SOLV
Price
$78.27
Change
-$0.08 (-0.10%)
Updated
Jul 2 closing price
Capitalization
13.55B
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDX vs SOLV

BDX vs SOLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDX vs. SOLV commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a StrongBuy and SOLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (BDX: $158.08 vs. SOLV: $78.27)
Brand notoriety: BDX and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDX: 68% vs. SOLV: 71%
Market capitalization -- BDX: $43.56B vs. SOLV: $13.55B
BDX [@Pharmaceuticals: Other] is valued at $43.56B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $13.55B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $150.88B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileSOLV’s FA Score has 1 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • SOLV’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDX and SOLV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 5 TA indicator(s) are bullish while SOLV’s TA Score has 3 bullish TA indicator(s).

  • BDX’s TA Score: 5 bullish, 4 bearish.
  • SOLV’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BDX is a better buy in the short-term than SOLV.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а +4.43% price change this week, while SOLV (@Pharmaceuticals: Other) price change was +0.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.05%. For the same industry, the average monthly price growth was +6.39%, and the average quarterly price growth was -4.54%.

Reported Earning Dates

BDX is expected to report earnings on Jul 30, 2026.

SOLV is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+3.05% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($43.6B) has a higher market cap than SOLV($13.6B). BDX has higher P/E ratio than SOLV: BDX (24.56) vs SOLV (9.00). BDX YTD gains are higher at: 4.976 vs. SOLV (-1.224). BDX has higher annual earnings (EBITDA): 4.97B vs. SOLV (2.49B). SOLV has less debt than BDX: SOLV (5.29B) vs BDX (17.3B). BDX has higher revenues than SOLV: BDX (22.2B) vs SOLV (8.26B).
BDXSOLVBDX / SOLV
Capitalization43.6B13.6B321%
EBITDA4.97B2.49B199%
Gain YTD4.976-1.224-407%
P/E Ratio24.569.00273%
Revenue22.2B8.26B269%
Total CashN/A561M-
Total Debt17.3B5.29B327%
FUNDAMENTALS RATINGS
BDX: Fundamental Ratings
BDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDXSOLV
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
67%
Momentum
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
63%
MACD
ODDS (%)
Bullish Trend 4 days ago
46%
Bearish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
46%
Bullish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
43%
Bullish Trend 10 days ago
65%
Declines
ODDS (%)
Bearish Trend 6 days ago
43%
Bearish Trend 6 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
50%
Aroon
ODDS (%)
Bearish Trend 5 days ago
36%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BDX
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGY5.060.10
+2.02%
Vaalco Energy
DTM144.590.81
+0.56%
DT Midstream
RNTX0.97N/A
N/A
Rein Therapeutics Inc
PMAX2.40N/A
N/A
Powell Max Limited
UNFI45.57-0.11
-0.24%
United Natural Foods

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
+3.39%
COO - BDX
54%
Loosely correlated
N/A
TMO - BDX
50%
Loosely correlated
+1.97%
BAX - BDX
48%
Loosely correlated
+4.43%
CNMD - BDX
48%
Loosely correlated
+3.27%
RVTY - BDX
45%
Loosely correlated
+0.82%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with RMD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then RMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
-0.10%
RMD - SOLV
47%
Loosely correlated
+4.24%
BAX - SOLV
46%
Loosely correlated
+4.43%
NVST - SOLV
44%
Loosely correlated
+1.69%
BDX - SOLV
44%
Loosely correlated
+3.39%
COO - SOLV
43%
Loosely correlated
N/A
More